evaluate the pharmaceuticals company saxenda on glp-1 efficacy / effectiveness Great (Oral) Scare GLP-1 Agonists: Using Semaglutide, Tirzepatide,
Description
These are less talked about and rarelyif everaddressed by healthcare providers
in: PubMed | Google Scholar 1 Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, Basel, Switzerland
Additional Use Cases in the Pipeline GLP-1s were a big deal for diabetes, then became a bigger deal for weight loss
An oral tablet formulation (semaglutide Rybelsus) is also available, taken once daily on an empty stomach
All patients with GORD (new or pre-existing) on these agents had significantly increased risk of developing Barretts oesophagus or a stricture (oesophageal stricture HR 1.284
